Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/2003
02/27/2003US20030040048 Nucleotide sequences coding polypeptide for use in the treatment of cancer, heart and viral diseases
02/27/2003US20030040044 Anti-dual integrin antibodies, compositions, methods and uses
02/27/2003US20030040042 Nucleotide sequences coding growth factor for use as wound healing and tissue repair agent
02/27/2003US20030040041 Nucleotide sequences coding polypeptide for use in the treatment of scarring and/or fibrosis
02/27/2003US20030040039 Nucleotide sequences coding polypeptide for use in the treatment of diabetes
02/27/2003US20030040022 Dopamine receptors and genes
02/27/2003US20030040014 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/27/2003US20030040013 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/27/2003US20030039999 B7 related protein-2 molecules and uses thereof
02/27/2003US20030039995 YS68 gene involved in primitive hematopoiesis
02/27/2003US20030039994 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of cancer
02/27/2003US20030039993 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of cancer
02/27/2003US20030039987 Defects in periaxin associated with myelinopathies
02/27/2003US20030039984 Sequences upstream of the CARP gene, vectors containing them and uses thereof
02/27/2003US20030039983 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer
02/27/2003US20030039972 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/27/2003US20030039971 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders
02/27/2003US20030039970 Diagnosing cancer in humans; obtain tissue sample, determine concentration of calreticulin in sample, compare to control, evaluate for cancer
02/27/2003US20030039969 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/27/2003US20030039968 Peptide for use in the treatment of cell proliferative and nervous system disorders
02/27/2003US20030039959 Detection of premature tumor cells in mammary gland tissue; obtain mammary gland tissue, incubate with diagnostic agent, monitor sample for binding and signal, presence of signal indicates premature cancer
02/27/2003US20030039740 Composition for enteral nutrition comprising fibres
02/27/2003US20030039698 Sustained-release preparation
02/27/2003US20030039694 Periadventitial delivery device
02/27/2003US20030039680 Buccal, polar and non-polar spray or capsule
02/27/2003US20030039669 Use of a composition containing an effective quantity of at least one chelating agent for partially or totally reducing the symptoms associated with histamine release in the organism
02/27/2003US20030039664 Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting
02/27/2003US20030039660 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
02/27/2003US20030039658 Probes for leukemia-associated translocation junctions and to identifv reagents promoting dissociation of those proteins from each other or inhibiting their association and to discover anti-HIV reagents
02/27/2003US20030039655 Novel engineered superantigen for human therapy
02/27/2003US20030039654 Amino acid sequence of parathyroid hormone/parathyroid hormone related protein modulating domains and a vehicle for to stimulate renal calcium reabsorption
02/27/2003US20030039652 Inhibiting endothelial monocyte activating polypeptide II
02/27/2003US20030039651 Administering tumor necrosis factor inhibitors, interleukin -1, -6, or -8 inhibitors, FAS (ligand) gene/protein inhibitors or interferon gamma inhibitors; nerve disorder treatments
02/27/2003US20030039647 Tetraspan protein and uses thereof
02/27/2003US20030039646 Receptor interacting protein, which binds to itself and to other intracellular modulatory proteins; treating tumor cells or HIV-infected cells
02/27/2003US20030039645 Humanised antibodies
02/27/2003US20030039644 Expression and purification of recombinant proteins from snake venom
02/27/2003US20030039643 Investigation, diagnosis and treatment of subjects suspected of or suffering from alpha-N- acetylglucosaminidase deficiency
02/27/2003US20030039641 Cells expressing anti-fc receptor binding components
02/27/2003US20030039639 Isolated stromal cells for use in the treatment of diseases of the central nervous system
02/27/2003US20030039635 Compositions and methods for WT1 specific immunotherapy
02/27/2003US20030039633 A replication-competent adenovirus vector comprising an adenovirus gene essential for replication; use as antitumor agent
02/27/2003US20030039632 Novel bacteriocins, transport and vector system and method of use thereof
02/27/2003US20030039631 Adenovirus p53 compositions and methods
02/27/2003US20030039630 Administering a therapeutically effective amount of ribavirin and interferon-alpha to treat the liver disease
02/27/2003US20030039629 Espression enhancer for protein synthesis inhibitory genes
02/27/2003US20030039628 Treating cancer or viral diseases for enhancing T-cell proliferation by administering an effective amount compound that inhibits the production or release of intercellular reactive oxygen metabolites
02/27/2003CA2459692A1 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
02/27/2003CA2458648A1 Secreted proteins
02/27/2003CA2458643A1 Nucleic-acid associated proteins
02/27/2003CA2458625A1 Transporters and ion channels
02/27/2003CA2457932A1 Sodium channel regulators and modulators
02/27/2003CA2457918A1 Mullerian inhibiting substance levels and ovarian response
02/27/2003CA2457823A1 Methods for diagnosing and treating neoplasias using nf-at transcription factors
02/27/2003CA2457789A1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
02/27/2003CA2457783A1 Oligonucleotide compositions and their use to induce apoptosis
02/27/2003CA2457781A1 Kgf polypeptide compositions
02/27/2003CA2457496A1 Gpcr-like retinoic acid-induced gene 1 protein and nucleic acid
02/27/2003CA2457436A1 Peptide arginals and methods for treating disseminated intravascular coagulation
02/27/2003CA2457321A1 Combinatorial methods for inducing cancer cell death
02/27/2003CA2457301A1 Porcine leptin protein, antisense and antibody
02/27/2003CA2457288A1 Excitatory glycine receptors and methods
02/27/2003CA2457164A1 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells
02/27/2003CA2457163A1 Derp1 and proderp1 allergen derivatives
02/27/2003CA2457148A1 Treatment of cancers by inhalation of stable platinum-containing formulations
02/27/2003CA2457143A1 In situ immunization
02/27/2003CA2457066A1 Human protooncogene kg-20 and protein encoded therein
02/27/2003CA2457043A1 Medicinal use of histone deacetylase inhibitor and method of evaluating antitumor effect thereof
02/27/2003CA2457008A1 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
02/27/2003CA2456988A1 Gas microsphere liposome composites
02/27/2003CA2456966A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
02/27/2003CA2456843A1 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine
02/27/2003CA2456753A1 Mammalian relaxin receptors
02/27/2003CA2456477A1 Antimicrobial cationic peptides and formulations thereof
02/27/2003CA2456470A1 Interleukin-2 mutants with reduced toxicity
02/27/2003CA2456158A1 Anti-aging and wound healing compounds
02/27/2003CA2455884A1 Treatment of muscular dystrophies and related disorders
02/27/2003CA2455827A1 Materials and methods for nerve grafting comprising degrading chondroitin sulfate proteoglycan
02/27/2003CA2454860A1 Hybrid interferon/interferon tau proteins, compositions and methods of use
02/27/2003CA2454756A1 Methods and compounds for the targeting of protein to exosomes
02/27/2003CA2451998A1 Anti-a.beta. antibodies
02/27/2003CA2446848A1 Derivatives of magainin
02/27/2003CA2423025A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels
02/26/2003WO2002018407A2 Antisense oligonucleotides against vanilloid receptor 1
02/26/2003EP1285967A2 Human retroviral packaging cell line
02/26/2003EP1285963A1 Human ZZAP1 protein
02/26/2003EP1285960A2 Virulence genes from Salmonella typhimurium
02/26/2003EP1285928A1 Antibiotics tripropeptins and process for producing the same
02/26/2003EP1285665A1 Liquid gonadotropin containing formulations
02/26/2003EP1285664A2 Methods of increasing lean tissue mass using OB protein compositions
02/26/2003EP1285663A1 Preventives for reinfection after liver transplantation
02/26/2003EP1285662A1 Reconstituted HDL for the treatment of stroke and ischemic conditions
02/26/2003EP1285660A1 Zinc-supplementary compositions for oral administration
02/26/2003EP1285087A2 Enzymatic assays for screening anti-cancer agents
02/26/2003EP1285074A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
02/26/2003EP1285071A2 Novel dual oxidases as mitogenic and endocrine regulators
02/26/2003EP1285068A2 Compounds and methods for the diagnosis and treatment of babesia microti infection
02/26/2003EP1285067A1 Cloning and sequencing of dac g5 allergen of dactylis glomerata pollen, preparation and use thereof
02/26/2003EP1285066A1 F-box containing protein
02/26/2003EP1285064A2 G-protein coupled receptors and uses therefor
1 ... 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 ... 3163